Achalasia management: the South American viewpoint

References

[1] Patti MG.Achalasia and other esophageal motility disorders..J Gastrointest Surg2011;15:703-7

[2] Andolfi C,Kavitt RT,Asti E.Importance of esophageal manometry and pH monitoring in the evaluation of patients with refractory gastroesophageal reflux disease: a multicenter study..J Laparoendosc Adv Surg Tech A2016;26:548-50

[3] Stanaway JD.The burden of Chagas disease: estimates and challenges..Glob Heart2015;10:139-44

[4] Gorchakov R,Wozniak EJ,Garcia MN,Murray KO.Trypanosoma cruzi infection prevalence and bloodmeal analysis in triatomine vectors of chagas disease from rural peridomestic locations in Texas, 2013-2014..J Med Entomol2016;53:911-8

[5] Antinori S,Bianco R,Galli M.Chagas disease in Europe: a review for the internist in the globalized world..Eur J Intern Med2017;

[6] Herbella FA,Del Grande JC.Are idiopathic and Chagasic achalasia two different diseases?.Dig Dis Sci2004;49:353-60

[7] Herbella FA,Patti MG.Achalasia 2016: treatment alternatives..J Laparoendosc Adv Surg Tech A2017;27:6-11

[8] Herbella FA,Stefani-Nakano S,Sakai P,Andreollo NA,de Castro Pochini C,Gagliardi D.Treatment of achalasia: lessons learned with Chagas' disease..Dis Esophagus2008;21:461-7